Skip to the guide

Care explained, one question at a time.

Use this guide to explore care choices; it is not a clinic.

Approval & rules

Approval and making medicine to order: the limits

This page explains why an online offer is not proof that a pharmacy may make BPC-157 for you. Check both drug approval and the rules about ingredients.

  1. The US drug-review agency is FDA, which stands for Food and Drug Administration.

    At the September 2026 check, no US medicine containing BPC-157 had FDA approval. FDA finding

    FDA also reported finding no approved BPC-157 product in any country at that time. FDA worldwide finding

  2. Compounding involves preparing a medicine to order, taking the place of a drug maker’s finished supply.

    FDA does not approve compounded drugs or assess their safety, effect and quality before they reach the market (September 2026 record). FDA compounding explanation

  3. FDA lists BPC-157 among ingredients that groups asked it to let pharmacies use. The page says its information is current as of April 22, 2026. FDA table

    Those groups took back their requests; that did not mean FDA gave permission.

    FDA gives no date for the withdrawal.

  4. In September 2026, BPC-157 met none of the ingredient rules for pharmacies making medicine for individual patients. FDA compounding framework

    It had no official written quality standard for the raw ingredient, was not part of an approved drug and was absent from the permitted ingredient list. FDA ingredient findings

    These are rules about permission to use an ingredient, rather than lab tests of the medicine. Ask which rule would allow the pharmacy to make it for you.

  5. FDA staff proposed against adding BPC-157 to that list ahead of the July 2026 advisory meeting. FDA staff proposal

    The advisory committee met in July 2026, but by September 28, 2026, FDA had not published how it voted. FDA meeting materials

    The missing record does not tell us the vote’s outcome.

    A committee vote is advice; it does not give pharmacies permission to use an ingredient.

    Changing the permitted ingredient list requires FDA to publish a draft rule, invite public comments and finish the rule process. FDA rule process